Skip to content

Clinical trials

Phase 2 Myelodysplastic Syndromes trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Phase 2 Country / region: Spain Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20071
20091
20101
20113
20121
20144
20152
20162
20171
20193
20201
20212
20221
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated6
Active, not recruiting3
Recruiting3
Withdrawn1
Enrolling by invitation1
Unknown status1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Celgene3
Janssen Research & Development, LLC3
GlaxoSmithKline2
Agios Pharmaceuticals, Inc.1
Asociación Andaluza de Hematología y Hemoterapia1
Basque Health Service1
Celgene Corporation1
Fundacion para el Estudio de la Hematologia y Hemoterapia en Aragon1
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes29
Leukemia, Myeloid, Acute8
Leukemia, Myelomonocytic, Chronic5
Cytopenia2
Anemia1
Anemia, Refractory, with Excess of Blasts1
Bronchiolitis Obliterans Syndrome1
Hematologic Diseases1
Hematologic Neoplasms1
Iron Overload1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.